DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ruplizumab
Ruplizumab
Modifications to the Harmonized Tariff Schedule of the United States To
W W W .Bio Visio N .Co M
I Regulations
A1089-Anti-Cd11a (Efalizumab)
Clinical Immunology Helen Chapel, Mansel Haeney Siraj Misbah and Neil Snowden
INN Working Document 05.179 Update 2011
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Monoclonal Antibody to CD40 Complex by an Antagonistic Human
New Targets in Systemic Lupus (Part 2/2)ଝ Walter A
Emerging Therapies in Immune Thrombocytopenia
Education Forum-Monoclonal Antibodies: Pharmacological
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
Customs Tariff - Schedule
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Biosimilar Antibodies & ELISA Kits
Rationale for CD40 Pathway Blockade in Autoimmune Rheumatic Disorders Pucino, Valentina; Gardner, David; Fisher, Benjamin
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
Top View
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
University of Birmingham Rationale for CD40 Pathway Blockade In
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Biovision Rev.11/16 for Research Use Only
Biovision 11/17 for Research Use Only
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
Anti-CD40L [Hu5c8 (Ruplizumab)] Standard Size Ab00447-2.0
Antibody-Drug Analogues
Assessment of the Evolution of Cancer Treatment Therapies
Pharmaabkommen A1 E
Targeting the CD40-CD40L Pathway in Autoimmune Diseases: Humoral Immunity and Beyond
Customs Tariff - Schedule Xxi - 1
1 New Therapies for Systemic Lupus Erythematosus — Past Imperfect
Anti-CD40L (Ruplizumab), Human Igg1 Antibody Catalog # ABV11788
Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names
WO 2012/160186 Al 29 November 2012 (29.11.2012) P O P C T
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
Biosimilar Monoclonalantibodies
Thalidomide - Wikipedia, the Free Encyclopedia
Assessment of the Evolution of Cancer Treatment Therapies
A1094-Anti-CD40L (Ruplizumab)
W W W .Bio Visio N .Co M
Dexamethasone to Reduce Stem Cell Accumulation in the Spleen
Combinations of an Anti-HER2 Antibody-Drug Conjugate and Docetaxel